BlossomHill Therapeutics, Inc. (BLSM)

Every official BlossomHill Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

BlossomHill Therapeutics, Inc. documents

• BlossomHill Therapeutics, Inc. 10-K 2026BLSM 10-K 2026: annual report for fiscal 2026
• BlossomHill Therapeutics, Inc. 10-K 2025BLSM 10-K 2025: annual report for fiscal 2025
• BlossomHill Therapeutics, Inc. 10-K 2024BLSM 10-K 2024: annual report for fiscal 2024
• BlossomHill Therapeutics, Inc. 10-K 2023BLSM 10-K 2023: annual report for fiscal 2023
• BlossomHill Therapeutics, Inc. 10-K 2022BLSM 10-K 2022: annual report for fiscal 2022
• BlossomHill Therapeutics, Inc. 10-Q 2026BLSM 10-Q 2026: quarterly report for fiscal 2026
• BlossomHill Therapeutics, Inc. 10-Q 2025BLSM 10-Q 2025: quarterly report for fiscal 2025
• BlossomHill Therapeutics, Inc. 10-Q 2024BLSM 10-Q 2024: quarterly report for fiscal 2024
• BlossomHill Therapeutics, Inc. 10-Q 2023BLSM 10-Q 2023: quarterly report for fiscal 2023
• BlossomHill Therapeutics, Inc. 10-Q 2022BLSM 10-Q 2022: quarterly report for fiscal 2022
• BlossomHill Therapeutics, Inc. 8-K 2026BLSM 8-K 2026: current report for fiscal 2026
• BlossomHill Therapeutics, Inc. 8-K 2025BLSM 8-K 2025: current report for fiscal 2025
• BlossomHill Therapeutics, Inc. 8-K 2024BLSM 8-K 2024: current report for fiscal 2024
• BlossomHill Therapeutics, Inc. 8-K 2023BLSM 8-K 2023: current report for fiscal 2023
• BlossomHill Therapeutics, Inc. 8-K 2022BLSM 8-K 2022: current report for fiscal 2022
• BlossomHill Therapeutics, Inc. DEF 14A 2026BLSM DEF 14A 2026: proxy statement for fiscal 2026
• BlossomHill Therapeutics, Inc. DEF 14A 2025BLSM DEF 14A 2025: proxy statement for fiscal 2025
• BlossomHill Therapeutics, Inc. DEF 14A 2024BLSM DEF 14A 2024: proxy statement for fiscal 2024
• BlossomHill Therapeutics, Inc. DEF 14A 2023BLSM DEF 14A 2023: proxy statement for fiscal 2023
• BlossomHill Therapeutics, Inc. DEF 14A 2022BLSM DEF 14A 2022: proxy statement for fiscal 2022
• BlossomHill Therapeutics, Inc. Form 4 2026BLSM Form 4 2026: insider trading filing for fiscal 2026
• BlossomHill Therapeutics, Inc. Form 4 2025BLSM Form 4 2025: insider trading filing for fiscal 2025
• BlossomHill Therapeutics, Inc. Form 4 2024BLSM Form 4 2024: insider trading filing for fiscal 2024
• BlossomHill Therapeutics, Inc. Form 4 2023BLSM Form 4 2023: insider trading filing for fiscal 2023
• BlossomHill Therapeutics, Inc. Form 4 2022BLSM Form 4 2022: insider trading filing for fiscal 2022
• BlossomHill Therapeutics, Inc. S-1 2026BLSM S-1 2026: registration statement for fiscal 2026
• BlossomHill Therapeutics, Inc. S-1 2025BLSM S-1 2025: registration statement for fiscal 2025
• BlossomHill Therapeutics, Inc. S-1 2024BLSM S-1 2024: registration statement for fiscal 2024
• BlossomHill Therapeutics, Inc. S-1 2023BLSM S-1 2023: registration statement for fiscal 2023
• BlossomHill Therapeutics, Inc. S-1 2022BLSM S-1 2022: registration statement for fiscal 2022
• BlossomHill Therapeutics, Inc. 13F 2026BLSM 13F 2026: institutional holdings for fiscal 2026
• BlossomHill Therapeutics, Inc. 13F 2025BLSM 13F 2025: institutional holdings for fiscal 2025
• BlossomHill Therapeutics, Inc. 13F 2024BLSM 13F 2024: institutional holdings for fiscal 2024
• BlossomHill Therapeutics, Inc. 13F 2023BLSM 13F 2023: institutional holdings for fiscal 2023
• BlossomHill Therapeutics, Inc. 13F 2022BLSM 13F 2022: institutional holdings for fiscal 2022

More companies